dr. mohammad haji aghajani

3

14th International Breast Cancer Congress & 4th International GI Cancer Congress

20-22 Feb 2019, Tehran. Iran

Dr. Mohammad Haji Aghajani Chancellor of Shahid Beheshti University of Medical Sciences

In the name of GOD Dear attendances For the past fourteen years, the Cancer Research Center of the Shahid Beheshti University of Medical Sciences has undertaken scientific and practical deepening of cancer-related sciences and has not denied any effort. Fourteen years is such a long years that needs a great deal as a backbone. Four years ago another congress has been added to cover all of the cancers. I am honored to welcome you to these two congresses and have the hope of accepting this presentation from Shahid Beheshti University of Medical Sciences. Today, the incidence of cancers and the amount of cancer associates has increased, and our country and the province of Tehran are no exception of these rates. Shahid Beheshti University of Medical Sciences, which has the majority of individuals in Tehran, has a new face in the process of cancer. Cancers which associate with infectious agents such as cervical and stomach cancers is declining, and cancers which associated with social and Lifestyle quality, such as breast and prostate, is on the increase. Knowing the exact changes in the incidence of cancers in the area which covered by the university and the way of care of them is one of the effective factors in providing more scientific services to the people. Reports from the Cancer Research Center indicate a significant reduction in the deaths of cancer patients in spite of their increased incidence, and this component is an important indicator of secondary and tertiary evaluation and prevention, which our university is proud to be point of this assessment. Cancer has created a prominent situation among the most advanced countries of the world and Islamic republic of Iran, with a totally different power among the non-communicable diseases, and we need to vigorously regulate and control these changes. I hope the 14th International Breast Cancer Congress and the 4th International Gastrointestinal Cancer congress will succeed for this servicing through people.


20-22 Feb 2019, Tehran. Iran4

Prof. Mohmmad Esmaiel Akbari Chairman

Head of Cancer Research Center, Head of 14th International Breast Cancer Congress

Head of 4th International Gastrointestinal Cancer Congress

In the name of GOD

Dear professors and attendances, Thanks God for succeeded of Cancer Research Center of Shahid Beheshti University of Medical Sciences in serving education to the community of medicine for the 14th years of breast cancer and 4th years of gastrointestinal cancer congresses. This year, we are proud to announce that the Cancer Research Center, with its 27 years report on breast cancer care, was able to publicize its brilliant results. In this article the 10 years and 5 years overall survival rate for young people under the age of 40 and over 40 years old reported as 80% and 91% respectively. And this proud relates to the all of the colleagues at the Cancer Research Center, who make this rate as equivalent to or better than the world's most advanced countries, especially at higher clinical levels. Our study showed that breast preservation is not only a standard scientific method of surgery, but also it increases the longevity and overall survival rate of the disease. And this issue is an emphasis on our tries during the past thirty years. In the case of gastrointestinal cancers, it is also a great honor for our country that the death record for the period from 2005 to 2014 decreased from about 82% to 30%, and this indicator is comparable to advanced countries. Our 5 years report from patients who treated with Intra Operative Radiotherapy (IORT), either in the form of boost or radical doses, was an emphasis on this very hard work of the Cancer Research Center, which shows a clear future for this therapeutic approach in Iran to all associates. This year, we succeeded in encouraging the launch of a biopsy of the lymph nodes (SLNB) after 13 years of effort to greatly expand this scientific method and make patients happy. This year, in collaboration with international organizations, we published dozens of major articles in the world, and dozens of other papers are being finalized, which will cover the appearance and care of cancers in Iran, including 5 articles in the Lancet 2018 that was published in number 392. At congresses this year, we are trying to use the expertise of both national and international scientists to expose the goals of our research to public judgment. All of our wishes are your satisfaction with those who are attending these congresses, and which gives us encouragement. Hope GOD and you will be satisfied with us. Successes of these ongoing congresses achieved because of dear respected prof. Mirzaei, the scientific secretory of 14th IBCC, and prof. Moradi, the scientific secretary of 4th IGICC. Absolutely they created an amazing meeting with using the previous experiences, knowledge and compassion. Of course, the situation of all my great colleagues in the executive branch at the Cancer Research Center and these two congresses is prominent. I also sincerely thank to them too.

5



Prof. Hamid Reza Mirzaei Scientific Secretary

Of The 14th International Breast Cancer Congress

In The Name Of God

Thanks GOD for the successful holding of the International Congress Regarding breast cancer. It gives me great pleasure to welcome you to 14th International Breast Cancer Congress of Iran (IBCC 2019). We are proudly home to some of the best and brightest medical minds who are leading the way in revolutionary discoveries that will save lives.The plan establishes long-term goals to prevent breast cancer, improve the experience of the cancer treatment,care system and increase survival. We know that a diagnosis of breast cancer can be challenging for the patient, their family, their friends and their community.This Congress brings together world leading experts to discuss current issues in breast disease including surgery, radio oncology, pathology,molecullar & genetic issues, breast radiology, IORT and early diagnosis will be discussed. I encourage you all to use this event as an opportunity to share ideas and strengthen international relationships to effectively address clinical and therapeutic problems in breast disease. This event is the result of worthy effort of scholarly and sympathetic members of the scientific and executive committees and my colleagues of cancer research center over the years.

Yours sincerely



Afshin Moradi Scientific Secretary

Of The 4th International Cancer Congress

In The Name Of God

Dear Colleagues, It is my great pleasure to welcome you on behalf of the International Conference on Gastrointestinal Cancers Organizing Committee, and to invite you to attend the International Conference on Gastrointestinal Cancers to be hosted in Tehran, Iran, 2019. This conference goes to the heart of all matters relating to gastrointestinal malignancies, and it brings together the best scientists from around the world allowing you to hear and meet those at the forefront of our practice, and is being held in an amazing location, SBMU School of Nursing and Midwifery. There will be delegates not only from Iran, but from the Europe and North America. Distinguished speakers will provide the most up-to-date reviews from liver, pancreas, stomach, and colorectal malignancies. The Gastrointestinal Cancers Congress 2019 should end with some strong take-home messages. To reach that goal we need multiple sources of evidence and different clinical experiences. We need your work to be shared. The Gastrointestinal Cancers 2019 Conference is a unique and unmissable opportunity to meet face to face with colleagues from different parts of the world. It is a major contribution for the development and consilience of knowledge. We look forward to welcoming you in Tehran, Iran. We hope you will join us to make The 2019 congress on The Gastrointestinal Cancers a memorable event!

7



Dr. Mohammad Hadizadeh Executive Secretary

In the name of GOD

Dear professors,Another year pasts and again we are attending in this ongoing International Breast Cancer Congress. The prominent result of previous congresses was promoting the development of space science and researches about care of patients with breast cancer in Iran. AS the breast cancer is the most common cancer among women and has a low incidence in men, it accounts also as one of the most important goals and focus areas in health systems. The average age of diagnosis among Iranian women is 45 to 55 years of age compared to other Western countries that is about ten years younger. Since early detection of breast cancer is directly linked with increased awareness, it can be a key component in the prevention and improvement the quality of the treatment. Now, after a year of holding the International Breast Cancer Congress, academic and administrative activities of the Congress have been completed. I, as the executive secretary of the 14th International Breast Cancer Congress have thanks and gratitude from the executive team for their unwavering cooperation. Their cooperation and tireless efforts make to alert the experts and access to updated scientific information. I hope that the experiences which gained from the former Congresses at Cancer Research Center of Shahid Beheshti University of Medical Sciences will also be held more fruitful of presented congress and these efforts will lead to the promotion of health.

Yours Sincerely,



Congress Organization

Executive CommitteeExecutive Director:

Maryam Karami

Responsible for International Relations: Dr. Narjes Mehrvar, Dr. Sanaz Tabarestani

Somayeh Zoghi pour Hosna Akbari Hossein Akbari Zeynab Aliee Seyed Mehdi Barazi Azam Bazarpour Reza Esbati Dr. Reyhaneh Gharehgozlou Sajedeh Alimohammadi Dr. Shiva Ghasemi Farhad Moshfegh

Prof. Mohmmad Esmaiel Akbari Chairman

of The 14th International Breast Cancer Congress & 4th International Cancer Congress

Dr. Hamidreza Mirzaei Scientific Secretary

of The 14th International Breast Cancer Congress

Dr. Mohammad Hadizadeh

Executive Secretary of The 14th International Breast Cancer Congress

& 4th International Cancer Congress

Afshin Moradi Scientific Secretary

of The 4th International Cancer Congress

9



Mirmusa Rashidosadat Narges Saberian

Organizer Cancer Research Center- Shahid Beheshti University of Medical Sciences

Colleagues Ministry of Health and Medical Education Cancer Research Centers of Universities of Medical Sciences Islamic Azad University Tehran Medical Branch Universities of Medical Sciences across Iran

APOCP Medical Council of the Islamic Republic of Iran Iranian Scientific Association of General Surgeon International society Intraoperative Radiation Therapy (ISIORT) Iranian Society of Radiation Oncology Iranian Scientific Association of Hematology and Oncology Iranian Society of Pathology

EURAMA Iranian Society of Radiology Iranian Nursing Scientific Association

EUSOMA Iranian Medical Education Scientific Association Charity Foundation for Special Diseases World Health Organization (WHO) European Institute of Oncology (EIO) United Nations Population Fund (UNFPA( St.Gallen Keynote Speakers from Iran, England, Italy, Australia, Iraq, Germany,

Qatar, Pakistan, …



10

14th International Breast Cancer Congress

Scientific Committee

Epidemiology and Social Medicine Dr.M.Mohseni Dr.AR.Mousavi Jarrahi Dr.H.Souri Dr.P.Yavari Dr.F.Zayeri

Dr.M.Asadi Lari Dr.A.Bahadori Dr.PH.Davis Dr.SH.Haghighat Dr.M.Khayam Zadeh (Director)

Nuclear Medicine Dr.R.Sadeghi Dr.MK.Shiroudi

Dr.M.Amouei (Director) Dr.M.Rafeiei Zadeh Dr.GH.Razei

Surgery Dr.M.Habibi (USA) Dr.Hadis (USA) Dr.M.Hadizadeh Dr.I.Harirchi Dr.E.Hashemi Dr.S.Hashemi Dr.M.Heydari Dr.R.Hiltebrand (Swiss) Dr.A.Hojat Dr.S.J.Hosseini Dr.M.Intra (Italy) Dr.N.Jadalizadeh Dr.MR.Javadi Dr.A.Joulaei Dr.MR.Kalantar Motamed Dr.A.Kaviani Dr.M.Khoramshahi Dr.A.Khoshkar Dr.J.Khoshnevis Dr.H.Mahmoud Zade Dr.K.Markopolous (Greece) Dr.N.Mansour Moshtaghi Dr.F.Meybodi (Australia) Dr.MR.Mir Dr.A.Mirmalek Dr.H.Moayeri Dr.N.Moeini Dr.A.Mojallal (France)

Prof.M.E.Akbari (Director) Dr.F.Abasvandi Dr.A.Abdollahi Dr.S.Alipour Dr.A.Afsharfard Dr.TMJ.AL – Lawati (Oman) Dr.J.Akbari Dr.M.Akhgari Dr.M.Akrami Dr.H.Almasi Dr.M.Ariana Dr.M.Asadi Dr.L .Asef Kabiri Dr.M.Atri Dr.KH.Ayazi Dr.P.Aziminejadan Dr.J.Benson (England) Dr.M.Bohlooli Dr.M.J.Cardoso (Italy) Dr.P.Daryani Dr.M.Davaei Dr.W.C.Dooley (USA) Dr.K.Dowlatshahi(USA) Dr.M.Ebrahimi Dr.F.Ebrahimfar Dr.ZH.Farhadi (Switzerland) Dr.MN.Forghani Dr.F.Golfam

11



Dr.F.Moradian Dr.SR.Mousavi Dr.M.Samsami Dr.S.Sayad Dr.S.Sayad Dr.S.Sehhat Dr.A.Seifi Dr.M.Shafahi Dr.J.Shakeri Dr.L.Shojaei Dr.F.Sirati Dr.Stefano Pompei (Italy) Dr.N.Tadayon Dr.F.Tavakoli Dr.A.Vahedi Dr.A.Yazdankhah Dr.R.Yeganeh Dr.MR.Zafarghandi Dr.AR.Zali Dr.F.Ziaei Dr.S.Zorrida (Italy)

Dr.B.Gol Oghlu (Turkey) Dr.R.Mousavi Dr.SM.Mousavi Naeini Dr.S.Motamed Dr.M.Motamedi Dr.M.Mozaffar Dr.M.Nabat Zadeh Golshan Dr.N.Nafisi Dr.M.Najafi Dr.M.Nava (Italy) Dr.F.Nazemian Dr.A.Olfatbakhsh Dr.R.Omranipour Dr.J.Peti (Italy) Dr.H.Peyvandi Dr.SM.Rabiei Hashemi Dr.B.Rahmani Dr.A.Razmavar Dr.J.Remi Garbi (France) Dr.KH.Rostami Dr.A.Rouyintan Dr.A.Salati

Psychology and Psychiatry Dr.S.Omidvari Dr.Patricia Fobeir (USA) Dr.SH.Vaziri

Dr.N.Beyraghi Dr.M.Firouzi Dr.T.Kermani Ranjbar (Director) Dr.F.Lotfi Kashani

Radiology Dr.J.Jalal Shokoohi Dr.M.Kalantari Dr.N.Kamangari (England) Dr.MH.Kharazi Dr.Z.Mahboubi Fouladi Dr.M.Nouri Dr.S.Sabouri Dr.M.Sanei Taheri Dr.N.Sedighi

Dr.F.Ahmadi Dr.N.Ahmadinejad Dr.A.Ameri Dr.Astani Dr.KH.Bakhtavar Dr.N.Behboudi Moghaddam Dr.SH.Dadgari Dr.M.Giti Dr.HR.Haghighatkhah (Director) Dr.D.Hendesi

Radiation Oncology Dr.M.Malekzadeh Moghani Dr.G.Mazdaei Dr.H.R.Mirzaei(Director) Dr.A.Moghadam Dr.I.GH.Mohammed(canada)

Dr.S.Almasi Dr.A.Ameri Dr.R.Anbiaei Dr.F.Andre(France) Dr.AM.Aref Pour



12

Dr.Mosalaei Dr.MA.Mousavi Zadeh Dr.H.Nasrolahi Dr.A.Nikou Far Dr.R.Orecchia(Italy) Dr.M.Picard Dr.A.Rakhsha Dr.S.Saedi Dr.R.Salek Dr.S.Salmanian Dr.M.Sanei Dr.M.Sardari Dr.M.Savad Kouhi Dr.H.Shahbazian Dr.G.Steger(Austria) Dr.SM.Tabatabeifar Dr.T.Taheri Panah Dr.M.Tajvidi Dr.F.Taslimi Dr.A.Yaghoubi Dr.SH.Yahyazadeh Dr.A.SH.Yousefi Kashi Dr.J.Zi (Netherlands)

Dr.F.Asrari(USA) Dr.S.Atrchian(canada) Dr.P.Azadeh Dr.S.Azghandi Prof.F.A.Calvo(Spain) Dr.G.Festner(Netherlands) Dr.H.Foudazi Dr.A.Ghanbari Motlagh Dr.MR.Ghavamnasiri Dr.P.Gorji Bayani Dr.P.Haddad Dr.K.Hadis(USA) Dr.P.Hajian Dr.S.Hemati Dr.S.Hemmati Dr.Hogo Raul Marsiglia (Italy) Dr.F.Homaei Dr.M.Houshiari Dr.A.Jafari Dr.SH.Kamian Dr.S.Loibl(Germany) Dr.A.Mafi Dr.Y.Makhdoumi

Obstetrics and Gynecology Dr.A.Akbari (Director) Dr.R.Alami Harandi Dr.M.Bahman Pour Dr.M.Hoseini

Dr.A.Abdalhafzi(Egypt) Dr.M.Afrakhte Dr.A.Aghazade Naeini Dr.L.Ajori

Genetic Dr.H.Najm Abadi Dr.E.Noushinfar Dr.M.Nowrouzi Niya Dr.N.Parsa Dr.M.Pornour DR.G.Somliai(Hungary) Dr.S.Tabarestani (Director) Dr.A.Taghavi Dr.VR.Yasaei Dr.H.Zali

Dr.GH.Ahangari Dr.MA.Faghihi(USA) Dr.R.Gharehgozlou Dr.M.Hashemi Dr.SH.Hodgson(USA) Dr.T.Langaei(USA) Dr.K.Majidzadeh Dr.P.Mehdipour Dr.S.H.Moghadam Niya Dr.S.Mohammad Pour Dr.A.Movafagh

13



Physical medicine and rehabilitation Dr.D.Eliaspour Dr.SM.Raygani (Director)

Dr.Angouti Ashnari Dr.MH.Bahrami

Medical Physics Dr.SR.Mahdavi (Director) Dr.A.Mostaar Dr.M.Shahani

Dr.MR.Aghamiri Dr.M.Bakhshande Dr.SH.Ghasemi Dr.M.Hosseini Daghigh

Hematology Oncology Dr.M.Khani Dr.A.Moghaddam Dr.M.Mojtabavi Naeini Dr.F.Mokarian Dr.D.Monadi Zadeh Dr.S.Najafi Dr.AA.Nejati Safa Dr.M.Razavi Dr.H.Rezvani Dr.N.Rostami Dr.T.Ruhstaller(swiss) Dr.R.Shahsavani Dr.J.Shams Dr.M.Tabaraei Dr.M.Vakili

Dr.M.M.Adib Sereshki Dr.H.Attarian Dr.S.Azambuja(Portugal) Dr.CH.Coumbes Dr.G.Curigliano(Italy) Dr.M.Ehsani Dr.F.Elahi Dr.F.Esfahani(Director) Dr.M.Ghadiani Dr.A.Ghavam Zadeh Dr.A.Haj Fathali Dr.M.Jahani Dr.H.Jalaei Khou Dr.GH.Jan Babaei Dr.M.Keyhani

Pathology and Laboratory Dr.M.Hoseyni

Dr.P.Hoseyn PourDr. Jahan Bin Dr.S.A.Mir Afshariyeh Dr.A.Nosrati Dr.H.Zham

Dr.A.Moradi (Director) Dr.M.Ahadi Dr.H.Boroumand Dr.A.Dehghan Dr.A.Eftekhari Dr.S.M.Eftekhari Dr.O.Emami Al Agha Dr.M.Gharib

Dr.H.Haji Zade Fallah

Health sciences Dr.A.Nourouzi Dr.Mouhebati

Dr.MR.Vaez Mahdavi Dr..A.Akbari Dr.M.Akbari



14

Nutritionist Dr.AM.Mortazavian Dr.Z.Nourollahi Dr.Sohrabvand Dr.MR.Vafa

Dr.S.H.Davoudi (Director) Dr.Doaei Dr.S.Esmaeili Dr.Gholamalizadeh

Traditinal medicine and Geriatrics Dr.N.Rezaei Pour Dr.H.Rezaei Zadeh(Director)

Dr.G.Heydari Dr.Mazrae Shahi Dr.A.Nowrouzi

Immonology Dr.S.Namaki

Mechanical and Aerospace Engineering Dr.M.Ebrahimi

Pediatrics Dr.R.Kelishadi Dr.KH.Rahmani

Immono Oncology Dr.S.Dermime (Qatar)

Midwifery and Nursing Dr.N.Khodakarami (Director) Dr.G.Mohammadi Dr.F.Nahidi Dr.M.Rasouli Dr.M.Simbar Dr.Zeynali

Dr.A.Abbas Zadeh Dr.F.Atash Zadeh Dr.F.Borhani Dr.M.Dolatian Dr.S.Hajian Dr.M.Ilkhani Dr.Z. Keshavarz

Electrotechnical Surgery Dr. M.Abdolahad

15



4th International Cancer Congress

Scientific Committee

Surgery Dr. F Moradian Dr. N Mansour Moshtaghi Dr. S R Mousavi Dr. M Mozafar Dr. H Nemati Dr. S Nikeghbalian Dr. M Samsami Dr. J Shakeri Dr. K Tulabi Dr. MR Zafarghandi Dr. H R Zamani

Prof.M.E.Akbari Dr. A Afshar fard Dr. F S Anaraki Dr. M Dehghan Dr. M S fazeli Dr. B Ghavami Dr.I.Harirchi Dr. M R Kalantarmotamedi Dr. J Khoshnevis Dr. R Kianmanesh Prof. SA Malek Hoseini

Radiology Dr. S A Astani Dr. P Dehghan H R Haghighatkhah Dr. M Saneitaheri

Radiation Oncology Dr. M Boroumand Dr. A Ghanbari Motlagh Dr. M Houshiary Dr. A Mafi Dr. H R Mirzaei Dr. M Sanei Dr. A yaghubi juibari

Genetic Dr. A Taghavi Dr. S Tabarestani

Hematology Oncology Dr.GH.Jan Babaei H Rezvani



16

Pathology and Laboratory Dr. F Bidari Dr. H Hajizadeh fallah D r. S Hafezi Bakhtiari Dr.P.Hosseinpour Dr. Z Kamali Dr. B Kazeminejad Dr. A Moradi (Director) Dr. M Saberafsharian Dr. SH Sabeti

Nutritionist Dr. S H Davoodi Dr. S Doaei Miss M Gholamalizaeh Dr. N Khoshnevis Dr. T Rezanistani Dr. M Shadnoush

Health sciences Dr.M Akbari Dr.T Mouhebati Dr. A.Norouzi Dr.MR Vaez Mahdavi

Epidemiology and Social Medicine Dr.SH.Haghighat Dr.H.Souri

Immonology Dr.S.Namaki

Gastroenterology Dr. S Abdi Dr. M Forutan Dr. R Malekzadeh Dr. A Sadeghi Dr. B Salehi Dr. SH Shahrokh Dr. N Zendehdel

Electrotechnical Surgery Dr. M Abdolahad

17


Scientific Program


14th International

Breast Cancer Congress 20-22 Feb / Tehran / Iran

18 18


Scientific Program


19


Scientific Program


Scientific Program


20 20


Scientific Program


Day 1: Wednesday 20 Feb 2019 Time Title Speaker

8:30 – 8:40 National Anthem & Recitation of Holy Quran

8:40 – 9:10 Scientific Secretary of Congress Dr.H.R.Mirzaei

9:10 – 9:30 President of Congress Dr.M.E.Akbari

Chairmen:

Dr.S.Sehhat, Dr.A.A.Ameri, Dr.M.Sardari, Dr.M.A.Mousavi Zadeh, Dr.M.Shafahi, Dr.M.Atri

9:30 - 10 Fertility issues in breast cancer

patients/Breast Cancer during pregnancy

Prof.S.Loibl

(Clinical Oncologist -

Germany)

10 – 10:30 Immune Checkpoint Inhibitors in Breast

Cancer: the PD-L1/PD-1 Story

Prof.S.Dermime

(Imono Oncologist -

Qatar)

10:30 - 11 Break

11 – 12:30

Panel discussion: What should we do in a patient with positive

sentinel lymph node?

Coordinator: Dr.M.Hadi Zadeh

Members: Dr.M.Rabie Hashemi, Dr.P.Azade, Dr.A.Mirmalek,

Dr.O.Emami Alagha, Dr.A.Astani, Dr.S.Azghandi,

Dr.S.Hashemi, Dr.SH.Razavi, Dr.M.Ghadiani, Dr.M.Amouie

12:30 – 13:30 The Prayer and Lunch

Chairmen: Dr.R.Mousavi, Dr.P.Daryani, Dr.H.Mahmoudzade,

Dr.R.Omrani Pour, Dr.A.Khoshkar, Dr.H.Mokarian

13:30 – 14 Management of the axilla Prof.J.Benson

(Surgeon – England)

14 – 14:30

Radiomics and radiogenomics in breast

cancer. A great opportunity to personalize

the radiation treatment

Prof.R.Orecchia

(Radiation Oncologist

– Italy)

14:30 – 14:45 Cancer Diagnostic Prob (CDP) in detection of

suspicious margin in breast cancer cases

Dr.Abdol Ahad

(Electrotechnical

Sergeon– Iran)

14:45 – 16:15

Panel discussion: BCS and MRM: what about overall survival and recurrence?

Coordinator: Dr.M.Mozafar

Members: Dr.A.Abdollahi, Dr.Z.Mahboubi Fuladi, Dr.M.Malek Zade,

Dr.A.Nosrati, Dr.M.Khayam Zade, Dr.L.Shojaei, Dr.N.Moeini,

Dr.H.Yahyazade, Dr.S.Najafi, Dr. S.Tabarestani

21


Scientific Program


Chairmen:

Dr.M.Jadalizade, Dr.F.Sirati, Dr.M.Mousavi Naeini, Dr.H.Peyvandi, Dr.S.Salmaniyan,

Dr.H.Foudazi, Dr.H.Jalaei Khou

16:15 – 16:30

Organs at Risk Dosimetry During

Low Energy

X-Ray Breast IORT

Dr.S.M.Hoseini Daghigh

(Medical Physics – Iran)

16:30 – 16:45

Gene expression profile of

circulating tumor cells in breast

cancer by RT-q PCR

Dr.A.Gharibi

(Genetics – Iran)

16:45 - 17

The Relationship between A245 T

Polymorphism of leptin gene and

breast cancer in women in Urmia

Dr.M.Hakimian

(Genetics – Iran)

22 22


Scientific Program


Day 2:Thursday 21 Feb 2019

TimeTitleSpeaker

8 – 9:30

Panel discussion: Practical solutions to reduce the financial burden

of cancer

Coordinator: Prof.M.E.Akbari

Members: Dr.I.Harirchi, Dr.GH.Jan Babaei, Dr.M.R.Vaez Mahdavi,

Dr.A.Ghanbari Motlagh, Dr.M.R.Zafarghandi, Dr.SH.Haghighat,

Dr.P.Hosseinpour, Dr.M.Akbari, Dr. A.Norouzi, Dr.A.Moradi,

Dr.H.Souri, Dr.T.Mouhebati

9:30 – 9:45 Welcoming Message

Prof. M.E Akbari

(head of cancer research

center and congresses)

9:45-10:00 Opening Notes

Dr. S Namaki

(Minister of Health and

Medical Education)

10:00-10:30 Appreciation of Honorable Prof. S A Malek Hoseini

10:30 - 11 Break

Chairmen:

Dr.S.Sehhat, Dr.M.Khoramshahi, Dr.A.Nikoufar, Dr.M.R.Ghavamnasiri,

Dr.H.Almasi, Dr.S.Hemeti, Dr.H.Yahya Zade, Dr.H.Shahbazian,

Dr.R.Mousavi, Dr.H.Atarian

11 – 11:30 Management of triple negative breast

cancer

Prof.G.Steger

(Clinical Oncologist – Austria)

11:30 - 12

Current indications in the

management of the axilla. The role of

radiation therapy

Prof.R.Orecchia

(Radiation Oncologist – Italy)

12 – 12:30 Surgical treatment of multiple

ipsilateral breast cancers

Prof.J.Benson


12:30 – 13:10 The Prayer and Lunch

13:10 – 13:30

Targeting breast cancer through

aromatase inhibition: a

biotechnological approach

Prof.A.T.Wahab

(Molecular Medicine –

Pakistan)

13:30 - 14 Advances in breast cancer

management

Prof.G.Steger

(Clinical Oncologist – Austria)

23


Scientific Program


14 – 15:30

Panel discussion: IORT in moderate risk B.C (cautionary group)

Coordinator: Dr.R.Salek

Members: Dr.N.Forghani, Dr.R.Mahdavi, Dr.M.Ahadi, Dr.F.Abas Vandi,

Dr.M.R.Javadi, Dr.N.Ahmadi Nejad, Dr.F.Tavakoli, Dr.H.Nasrollahi

Dr.M.Savad Kouhi

Chairmen:

Dr.S.Almasi, Dr.S.Alipour, Dr.A.Vahedi, Dr.A.Razmavar, Dr.M.Sanei,

Dr.A.M.Aref Pour

15:30 - 16

New treatment

New evolvement in HER2+ breast

cancer

Prof.S.Loibl


Germany)

16 – 16:15

Investigation the incidence of breast

cancer among women in Hormozgan

in 2015

Dr.N.Roozbeh

(Medical Physics – Iran)

16:15 – 16:30

Male breast cancer in patients

referred to radiation oncology

centers of Mashhad University of

Medical Sciences from 1991 - 2012

Dr.M.Nouri

( Iran)

24 24


Scientific Program


Day 3: Friday, 22 Feb 2019

Time Title Speaker

Chairmen:

Dr.M.R.Mir, Dr.N.Khodakarami, Dr.J.Akbari, Dr.M.Ebrahimi, Dr.B.Rahmani,

Dr.A.Ghavam Zade, Dr.A.Kaviani, Dr.R.Shahsavani

8:30 – 8:45 Assessment of Risk Factors of Breast

Cancer in Al-Najaf Province

Dr.A.Al-fahham

(Iraq)

8:45 – 9:15

Downregulation of the cell surface

PD-L1 and its upregulation in the

nucleus of breast cancer cells by

Doxorubicin treatment

Prof.S.Dermime

(Imono Oncologist - Qatar)

9:15 – 9:45 Locally advanced breast cancer-

surgical aspects

Prof.J.Benson


9:45 – 10:15 Neoadjuvant Therapy in Triple

Negative Breast Cancer

Prof.S.Loibl


Germany)

10:15 – 10:45 Break

10:45 – 11:45

Panel discussion:Which patients will have surgery at first?

Coordinator: Dr.P.Azimi Nejadan

Members: Dr.A.Joulaei, Dr.A.Rakhsha, Dr.H.Zham, Dr.GH.Razei,

Dr.F.Ziaei, Dr.M.Ariana, Dr.N.Nafisi, Dr.F.Taslimi, Dr.M.Kalantari,

Dr.H.Rezvani

11:45 - 13

Panel discussion:Triple negative metastatic patients.

Coordinator: Dr.H.R.Mirzaei

Members: Dr.M.Akhgari, Dr.H.Haji Zade Falah, Dr.SH.Dadgari,

Dr.A.Hojat, Dr.S.Sayad. Dr.R.Anbiyaei, Dr.P.Hajian, Dr.M.Tabaraei,

Dr.A.Movafagh

25


Scientific Program


time title Coordinator Wednesday 20 Feb 2019

16:30 – 17:30 Mammography Interpretation

Dr. Astani

time title Coordinator

Wednesday 20 Feb 2019 16 – 17:30

Breast surgery Prof.Akbari Prof.Benson


Thursday 21 Feb 2019 13 - 15

Chemotherapy Dr.Jafari

time title speaker

13 - 13:30 Use of the port in patients undergoing chemotherapy

and necessary care Ms.Zeynali

13:30 - 14 Chemotherapy in patients with liver and infectious

diseases Dr.P.Gorji

14 – 14:30 Chemotherapy in patients with heart disease, kidney

disease

Dr.T.Taheri Panah

14:30 - 15 Chemotherapy in elderly

patients Dr.A.Jafari

time title Coordinator Thursday 21 Feb 2019

11 – 12:30 Contouring of breast lymph

node Dr.S.Saedi


Thursday 21 Feb 2019 15:30 - 17

Sentinel lymph node Prof. Akbari

26 26


Scientific Program


27


Scientific Program


Oral Presentation


28 28


Oral Presentation


First day

2019 February 20, Wednesday

SUBJECT AUTHOR/AUTHORS TIME CODE

Downregulation Of MICAL3 In

Breast Cancer

Mina Zafarpiran,

Mohammad Khalaj-kondori 9:05-9:10 R1-01

99mtc-HYNIC-(Tricine/EDDA)-

FROP Peptide For MCF-7

Breast Tumor Targeting And

Imaging

Sajjad Ahmadpour,

Zohreh Noaparast,

Seyed Mohammad Abedi,

Seyed Jalal Hosseinimehr

9:10-9:15 R1-02

Discordance Of HER2

Expression In Primary Breast

Cancer And Related Axillary

Lymph Node Metastasis

Azar Naimi , Bahar Saffar ,

Fereshteh Mohammadizadeh

9:15-9:20 R1-03

Specific Delivery Of ZHER2

Affibody-Conjugated Gold

Nanoparticles As

Radiosensitizer To HER2-

Overexpressing Malignant

Cells

Aminollah Pourshohod,

Mostafa Jamalan,

Majid Zeinali,

Alireza khairollah

9:20-9:25 R1-04

Gene Expression Profile Of

Circulating Tumor Cells In

Breast Cancer By RT-Q PCR

Armin Gharibi,

Masoud Sohrabi rad 9:25-9:30 R1-05

Relationship With

Investigation Of PTEN-Mir 127-

5p Breast Cancer In Women Of

Ardabil Province

Ramin Nouri ,

Morteza Hakimian ,

Sasan Talaneh

9:30-9:35 R1-06

Investigating The Association

Of A2256G Polymorphism Of

MDR1 Gene With Breast

Cancer In Women In Ardebil

Ramin Nouri,

Morteza Hakimian,

Sasan Talaneh

9:35-9:40 R1-07

A Survey On The Association Of

Mir520 Gene Polymorphism

With Breast Cancer In Women

In Urmia

Sasan Talaneh ,Ali Sedghiani-

Far ,Noshine Ansafi ,

masome abasi

9:40-9:45 R1-08

Investigation Of The Repeat Sequence Length Of CA Intron 1 Of GATA3 Gene With Breast

Cancer In Women Of West Azarbaijan Province

Sasan Talaneh, Ali Sedghiani-Far ,

Noshine Ansafi masome abasi

9:45-9:50 R1-09

29


Oral Presentation


The Investigation Of The

Relationship Between FGFR

Mutation G1138T And Breast

Cancer In West Azarbaijan

Province

Morteza Hakimian ,

Ramin Nouri, Sasan Talaneh

9:50-9:55 R1-10

Investigating The Relationship

Between SHBG G247E

Polymorphism And Breast

Cancer In Women In Urmia

Sasan Talaneh ,

Ali Sedghiani-Far ,

Noshine Ansafi ,

Ramin Noori ,

Morteza Hakimian

9:55-10:00 R1-10

Investigating The Relationship

Between The 206 A / T

Polymorphism Of VEGF Gene

And Breast Cancer In Women

Of West Azarbaijan Province

Sasan Talaneh,Zahra

Azad,Razieh Azad-e ,Ramin

Nouri, Morteza Hakimian

10:00-10:05 R1-11

Downregulation Of Differentiation Antagonizing

Long None Coding RNA (DANCR) And Its Cerna

Network Target Gene, CTNNB1, In Breast Cancer Tissues And

Adjacent Non-Neoplastic Tissues Of Iranian Turkish

Breast Cancer Patients

Zeynab Shaghaghi Torkdari, Mohammad Khalaj Kondori, Mohammad Ali Hosseinpour

Feizi, Vahid Montazeri

10:05-10:10 R1-12

Break 10:10-10:40

In Silico Design Of A Novel

Peptide Inhibitor Derivative Of

Pediocin CP2 Affecting Breast

Cancer

EnsiehsadatEmadi,

SomayehReiisi

10:50-10:55 R1-13

Study Of CYP1A1

Polymorphisms In Women

With Breast Cancer In East

Azarbaijan Province

Hamideh Mohammadzadeh

10:55-11:00 R1-14

Overexpression Of Mir-

191 Inhibits Doxorubicin

Induced Apoptosis In MCF7

Breast Cancer Cell Line

Shirin Eyvazi,

Vahideh Tarhriz

11:00-11:05 R1-15

Investigation On The Effect Of

Quercetin Suspended

Nanoparticles On Cancer Stem

Cell Breast Cancer

Fatemeh Eivaz Damerchi

Darsi, Hakimeh Zali, Saeed

Hesami Tackallou

11:05-11:10 R1-16

30 30


Oral Presentation


Overexpression Of Mir-

191 Down-Regulates P53 In

MCF7 Breast Cancer Cell Line

Shirin Eyvazi, Vahideh

Tarhriz 11:10-11:15 R1-17

Effect Of Bfgf Peptide

Antagonist On Mouse Model

Breast Tumor Through

ERK/MAPK And PI3K/AKT

Signaling Pathways

Mehrzad Jafarzadeh ,

Shahrazad Ghadiriyan ,

Mohsen Asghari ,

Mohammad Taghi Joghataei ,

Mohammad Hashemi

Bahremani,

Kazem Mousavizadeh

11:15-11:20 R1-18

Early Detection Of Breast

Cancer Using Circulating

Mirnas In Peripheral Blood

Marzieh Ahmadi, Hanieh

Sadeghi ,Aryan Kamal,

Bahareh Shayesteh Pour,

Hamid Gourabi ,Andreas

Keller, Mehdi Totonchi

11:20-11:25 R1-19

A Brief Description A Bout

Mirna And Breast Cancer

Maryam etemadi, samareh

gooshki 11:25-11:30 R1-20

Regulation Of BAX/BCL2 Gene

Expression In Metastatic

Breast Cancer By Docetaxel –

Loaded Human Serum Albumin

Nanoparticles

Marzieh Kordezangeneh,

Shiva Irani,

Reza Mirfakhraie,

Mehdi Esfandyari-Manesh,

Fatemeh Atyabi ,

Rassoul Dinarvand

11:30-11:35 R1-21

Comparative Proteomic

Analysis Of Breast Cancer

Tissue And The Adjacent

Normal Tissue In Iranian

Patients With HER2 Negative

Ductal Carcinoma Of Breast

Mayram Amiri-

Shoar,Masoumeh Hosseini,

Mitra Arianmanesh,

Reza Eghdam-Zamiri,

Shahrokh Attarian,

Ali Awsat Mellati

11:35-11:40 R1-22

Comparison Of The Addition Of

Vitamins A And E To The Drug

Diet Of Women With Breast

Cancer Prone To Intravenous

Thrombosis Under

Chemotherapy: Double-Blind

Clinical Trial

Dara Alvandfar,

Mohammad Reza Katani,

Nafiseh Arefi,

Abbasali Dorosti,

Majid Montazer

11:40-11:45 R1-23

Effect Of Gallic Acid On Human

Breast Cancer Cells In

Presence Of Low Level Laser

Irradiation

Zohreh Hoseinmardi,

Zahra Kianmehr,

Khatereh Khorsandi

11:45-11:50 R1-24

31


Oral Presentation


Cytotoxicity Of TPSF Small

Molecule On MCF-7 Breast

Cancer Cells In Hydrogel

Scaffold

Kiavash Hushmandi,

Saad Gooraninejad,

Elham Hoveizi,

Mohammad Reza Tabandeh

11:55-12:00 R1-26

The Effect Of Vitamin A On

MCF-7 Cell Viability

Ebrahim Rahmani

Moghadam, Leila Jafaripour,

Teimour Tabari,

Farid Hashemi,

Amirhossein Zabolian,

Amirhossein Milani,

Gholamhossein Darya

12:00-12:05 R1-27

Serum Level Of Colony

Stimulating Factors,

Granulocyte, Monocyte And

Granulocyte-Monocyte, In

Peripheral Blood Of Patients

With Breast Cancer

Zahra Faghih,

Parisa Karimzadeh,

Fatemeh Eghbali,

Somayeh Rezaeifard,

Mahboobeh Razmkhah

12:05-12:10 R1-28

Evaluation Of Bovine

Leukemia Virus Infection In

Human Breast Tissue

Mohaddeseh Khalilian,

Seyed Masoud Hosseini,

Omid Madadgar

12:10-12:15 R1-29

Identification Of Novel Single

Chain Fragment (Scfv)

Antibody Against CD24, A New

Molecular Marker In Breast

Cancer

Shirin Eyvazi,

Bahram Kazemi,

Mojgan Bandehpour,

Siavoush Dastmalchi

12:15-12:20 R1-30

In Silico Pertuzumab Antibody

Affinity Maturation To

Improve Breast Cancer

Immunotherapy

Shirin Eyvazi,

Zahra Payandeh 12:20-12:25 R1-31

The Relationship Between

Resilience With Self-

Compassion, Social Support

And Sense Of Belonging In

Women With Breast Cancer

Saeedeh Alizadeh,

Shahriar Khanahmadi,

Abouali Vedadhir,

Samira Barjasteh

12:25-12:30 R1-32

Determinants Of Breast Cancer

Screening By Mammography In

Women Referred To Health

Centers Of Urmia, Iran.

Fatemeh Moghaddam

Tabrizi, Sakineh

Vahdati, Shahriar

Khanahmadi,

Samira Barjasteh

12:30-12:35 R1-33

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249445/









https://www.ncbi.nlm.nih.gov/pubmed/?term=Tabrizi%20FM%5BAuthor%5D&cauthor=true&cauthor_uid=29693968

https://www.ncbi.nlm.nih.gov/pubmed/?term=Tabrizi%20FM%5BAuthor%5D&cauthor=true&cauthor_uid=29693968

https://www.ncbi.nlm.nih.gov/pubmed/?term=Vahdati%20S%5BAuthor%5D&cauthor=true&cauthor_uid=29693968

https://www.ncbi.nlm.nih.gov/pubmed/?term=Vahdati%20S%5BAuthor%5D&cauthor=true&cauthor_uid=29693968

https://www.ncbi.nlm.nih.gov/pubmed/?term=Khanahmadi%20S%5BAuthor%5D&cauthor=true&cauthor_uid=29693968

https://www.ncbi.nlm.nih.gov/pubmed/?term=Khanahmadi%20S%5BAuthor%5D&cauthor=true&cauthor_uid=29693968

https://www.ncbi.nlm.nih.gov/pubmed/?term=Barjasteh%20S%5BAuthor%5D&cauthor=true&cauthor_uid=29693968

32 32


Oral Presentation


The Effect Of Family-Based

Intervention Program On

Managerial Self-Efficacy

Related To Chemotherapy

Symptoms In Iranian Patients

With Breast Cancer; A

Randomized Control Trial

Saeedeh Alizadeh,

Fatemeh Moghaddam

Tabrizi, Shahriar

Khanahmadi, Samira

Barjasteh

12:35-12:40 R1-34

The Effect Of Family-Based Intervention

On FOCUS Program On The Quality Of

Life In Patients With Breast Cancer

Undergoing Chemotherapy; A

Randomized Clinical Trial

Samira Barjasteh ,

Faraz Tayyar,

Amin Safaripour,

Shahriar Khanahmadi

12:40-12:45 R1-35

The Effect Of Breastfeeding

And Diabetes On Breast Cancer

In Women With Breast Cancer

Referring To Cancer Research

Center Of Shahid Beheshti

University During 2012-16

Mohadeseh Rahbar

,Farshid Aaliazar 12:45-12:50 R1-36

Forecasting And Discovering

Association Relations

Weighted Between The

Characteristics Of Breast

Cancer Patients

Seyed Mohammad Saleh

Hadavi, S.R.Khayami ,

Elham Nadimi 12:50-12:55 R1-37

Exploring Of Family Social

Support After Mastectomy In

Women Referring To Omid

Hospital In Mashhad In 2018

Seyyedeh Sara Afrazandeh,

Raheleh Rajabi,Maryam

Ebrahimi, FaribaAsadi

12:55-13:00 R1-38

Cardiovascular disease and

mortality after breast

cancer in postmenopausal

women: Results from the

Women's Health Initiative

Seyed Ehsan Asadi ,Anahita

Shabanian-Sodabe

Mohamadi ,Ahmad Rahime,

Faeze Mazareei

13:00-13:05 R1-39

The effect of lower limb

stretching exercises on

reducing the potential of

venous thrombosis in breast

cancer patients under

chemotherapy: Double-blind

clinical trial

Dara Alvandfar,

Mohammad Reza Katani,

Nafiseh Arefi, Abbasali

Dorosti, Majid Montazer

13:05-13:10 R1-40

https://jamanetwork.com/journals/jama/fullarticle/645514

https://jamanetwork.com/journals/jama/fullarticle/645514

33


Oral Presentation


Second day

2019 February 21 , Thursday SUBJECT AUTHOR/AUTHORS TIME CODE

Breast Cancer Survival and Reproductive Factors:

A Follow up Study on Parous Women with Breast Cancer in

Iran

Ghasem Yadegarfar, Somaye Momenian, Mohammad Esmaeil

Yadegarfar, Mohammad Esmaeil Akbari

14:30-14:35 R2-01

Relationship between Preeclampsia and Breast

Cancer : A case-control study Zohre Sheikhan 14:35-14:40 R2-02

Hand Massage + Bandage Massage Weekly Before Mastectomy Surgery on

Lymph Nerve: A Clinical Trial

Dara Alvandfar, Mohammad Reza Katani,

Nafiseh Arefi, Abbasali Dorosti, Majid Montazer

14:40-14:45 R2-03

Breast Reconstruction Surgery after

mastectomy:Inevitable Necessity

Seyyedeh Sara Afrazandeh, , Maryam Ebrahimi,

Raheleh Rajabi FaribaAsadi

14:45-14:50 R2-04

The Effectiveness of Religious-spiritual education on the self-efficacy of Women

with Breast Cancer

Farzane Nasiri, Zohre Keshavarz، Mohamadhasan

Davazdahemami, Saeed Karimkhani Zandi,

Malihe Nasiri

14:50-14:55 R2-05

The effect of counseling on self-efficacy in mastectomized

women: a randomized controlled trial

Monireh Hamed Biabayani, Mojgan Mirghafourvand,

Sakineh Mohammad-Alizadeh Charandabi

14:55-15:00 R2-06

Assessment of relationship between medication and estimated risk of breast

cancer using Gail model among

women in southeastern Iran, 2017-18

Hossein Ansari , Ali Yousefzadeh

15:00-15:05 R2-07

Survey Of Knowledge, Worry And Screening Behavior

Towards Breast Cancer Among Female Students Of Ahvaz Jundishapur University of Medical Sciences in 2018

Pouriya Darabiyan, Hajar Sadeghi, Ali Reza Rafi,

Zeinab Raiesifar, Maryam Ghanavati, Kourosh Zarea

15:05-15:10 R2-08

34 34


Oral Presentation


Investigating the Attention to Parameters of Environmental

Health Related to Breast Cancer

Zahra Aghalari , Somayeh Jafarian

15:10-15:15 R2-09

The association of chronic diseases with breast cancer in

Alzahra hospital of Tabriz

Raheleh Janani . Rogayeh Purreza,

Nahid Tahmasebpur, Maryam Vahidi

15:15-15:20 R2-10

Impact of Factors on recurrence of Patients with of breast cancer using Weibull

Cure Model

Fahimeh Ghasemi , Ali Akbar Rasekhi , Shahpar Haghighat

15:20-15:25 R2-11

C.novyi_NT: a promising approach to treat breast

cancer

Fatemeh Abedi Jafari, Asghar Abdoli ,

Reza Pilehchian, Neda Soleimani,

Seyed Masoud Hosseini

15:25-15:30 R2-12

Exploring of family social support after mastectomy in

women referring to Omid Hospital in Mashhad in 2018

Seyyedeh Sara Afrazandeh, Raheleh Rajabi,Maryam Ebrahimi,FaribaAsadi

15:30-15:35 R2-13

Effects of a saffron based syrup on fatigue in breast cancer patients: A double-blind randomized placebo-

controlled clinical trial

Ghazaleh Heydarirad, Hamidreza Mirzaei,

Reyhaneh Gharehgozlou, Shirin Fahim,

Parastoo Hajian

15:35-15:40 R2-14

Primary breast cancer with metastatic and non-

metastatic: Demographics and clinical features

Afsoon Taghavi , Gohar Mohammadi

15:40-15:45 R2-15

Apoptotic Effect of Glacium flavum extract on MCF-7

Cancer Cells

Ebrahim Rahmani Moghadam, Leila Jafaripour,

Reza jahangiri, Farid Hashemi, Gholamhossein

Darya, Amirhossein Milani, Amirhossein Zabolian.

15:45-15:50 R2-16

The Relationship Between Glutathione S Transferase Polymorphism And Breast Cancer In Women Of West

Azarbaijan Province

Sasan talaneh, Zahra azad kasb , noshin ensafi

15:50-15:55 R2-17

35


Oral Presentation


Poster Presentation 14th International Breast Cancer Congress

36 36


Poster Presentation


First day ( Unit 1 )

2019 February 20, Wednesday

SUBJECT AUTHOR TIME CODE

The combination of Coffee and

tamoxifen is effective against

breast cancer

Ghadiriyan Shahrazad,

Jafarzadeh Mehrzad ,

Mohammad Najafi

9:00-9:20 P1-01

Predictors of adopting the

breast cancer preventive

nutritional behaviors among

women of reproductive age

based on the Constructs of the

Bandura Social Cognitive Theory

Mohammad Hosein Taghdisi,

Tahereh Dehdari,

Alireza Dehnabi, Mitra Zarati

9:20-9:40 P1-02

Unmet Health needs and

Concerns of women with breast

cancer from the health care

system and health providers - a

qualitative study

Amin Safaripour,

Samira Barjasteh, Zohreh

khakbazan , Faraz Tayyar

9:40-10:00 P1-03

The effect of lower limb massage

with almond oil during

chemotherapy in women with

breast cancer: clinical trial

Dara Alvandfar,Mohammad

Reza Katani, Nafiseh Arefi,

Abbasali Dorosti, Majid

10:00-10:20 P1-04

Effectiveness of Acceptance and

Commitment therapy on the

Depression, Anxiety and Stress

among patients with breast

cancer

Mohammad Sadegh Sarizadeh

10:20-10:40 P1-05

The Incidence of Breast Cancer

in Iranian Women and Men; a

systematic review and meta-

analysis

Authors: Samira Beiranvand,

Kourosh Zarea, Parisa

Sheinijaberi

10:40-11:00 P1-06

Investigating Effective Factors

on Breast Self-examination

Behavior in Iranian Employed of

Medical Careers

Saeed Bashirian ,Majid Barati ,

Younes Mohammadi ,

Leila MoaddabShoar ,

Mitra Dogonchi

11:00-11:20 P1-07

37


Poster Presentation



2019 February 20 , WednesdaySUBJECT AUTHOR TIME CODE

Predictors of Quality of Life of Breast Cancer Patients

Fatemeh Mirzaei, Roghaiyeh Nourizadeh, Azizeh

Farshbaf-Khalili 9:00-9:20 P2-01

Mammography perceptions among women in an Iranian setting: A qualitative study

Mardi Afrouz, Refahi soheila, Madadzadeh Mitra

9:20-9:40 P2-02

The effect of counselling on breast cancer awareness in

Iranian rural women: a randomized controlled

clinical trial

Parvin Alizadeh Sabeg, Esmat Mehrabi, Roghaiyeh Nourizadeh,

Hamid Poursharifi, Saeed Mousavi

9:40-10:00 P2-03

Reconstruction of feminine identity: the strategies of

Iranian women with breast cancer for cope with body

image altered

Sharareh Zeighami mohammadi, Sima Mohammad Khan

Kermanshahi, Zohreh Vanaki10:00-10:20 P2-04

The Comparison of knowledge and practice of

women who referred to health centers in

Kermanshah with the same center's personnel in

regarding prevention of breast cancer in 2016

Vahab karamivand , Soroush maazinezhad

10:20-10:40 P2-05

Investigating the Survival Rate and Some Factors

Affecting Breast Cancer in Women

Arezoo Shayan , Batul Khodakarami,

Farkhondeh Jamshidi10:40-11:00 P2-06

The Effect of Spirituality on Quality of Life in Women with Breast Cancer: The

Role of Hope and Educational Attainment

Mobin Mohammadinezhad , Saeed Pahlevan Sharif, Rebecca H

Lehto, Mohammadreza Amiri, Ashraf Sadat Ahadzadeh, Hamid Sharif Nia, Ali Akbar Haghdoost ,

Fatemeh Khoshnava, Amir Hossein Goudarzian

11:00-11:20 P2-07

Assessment of different environmental factors for

Breast Cancer Among Women

Masoomeh asadi, Alieh afsharnia, shahin mazidi 11:20-11:40 P2-08

38 38


Poster Presentation



2019 February 20 , Wednesday SUBJECT AUTHOR TIME CODE

The Effect of a SMS-based Education Intervention on

Improving the Breast Cancer Preventive

Nutritional Behaviors Among Women Based on

the Constructs of the Bandura Social Cognitive

Theory

Mohammad Hosein Taghdisi, Tahereh Dehdari,

Alireza Dehnabi, Mitra Zarati

9:00-9:20 P3-01

Smoking and Breast Cancer: A Systematic

Review and Meta-Analysis of Iranian Studies

Bibi Hajar Zahmatkesh, Ahmad Khosravi, Afsaneh

Keramat, Nasrinossadat Alavi

, Reza Chaman

9:20-9:40 P3-02

The effect of education using “Problem Base

learning" method on the lifestyle of patients with

breast cancer

Hossein Feizi , Ronak Vakili Tajareh, Naser Rashadmanesh

9:40-10:00 P3-03

Effectiveness of Stress Coping Training on

Immune System and Pain Level in Patients with

Breast Cancer

Dr.M.Dorchin, Dr.A.K.Sheikhi, Dr.M.Akbari

10:00-10:20 P3-04

Dual role Transforming Growth Factor‑β in breast

cancer

Nahid Nafissi Shima Sadat Hashemi Madani

10:20-10:40 P3-05

The co-effect of shikonin and metformin on breast

cancer cell survival

Pegah Ghavidel, Zahra Nayeri, Mossa Gardaneh

10:40-11:00 P3-06

The effect of coping skills training on the quality of life among daughters of

mothers with breast cancer

Sedighe Khanjari , Mina mianji, Mitra Hakim

shooshtari, Hamid Haghani 11:00-11:20 P3-07

Incidence of breast cancer in Tehran province in

2014: results of the Iranian National

Population-based Registry

Dr. Gohar Mohammadi, Dr.Pardis Shojaei, Dr. Afsoon Taghvi,

11:20-11:40 P3-08

39


Poster Presentation


first day ( Unit 1 )


Frequency Of Sexual Dysfunction In Treated

Women Suffering Breast Cancer Refered To Surgical

Clinic S In Tonekabon

majid pouya paria bodduhi behruz

gholizadeh 14:30-14:45 P1-01

Early Detection Of Breast Cancer Through Liquid

Biopsy Using Deep Learning Technology

Amir Daaee, Mohammad Taheri, Soudeh Ghafouri-Fard, Hossein Mohammad-Rahimi,

Hosein Kazazi

14:45-15:00 P1-02

Using Machine Learning Techniques For Predicting

Breast Cancer

Mohammad Noorchenarboo, Mahboubeh Parsaeian

15:00-15:15 P1-03

Analysis Of Knowledge And Attitude Of Nursing Students Of Neyshabur Medical School About Breast Cancer In 2018.

Seyyedeh Sara Afrazandeh,Nadia

Naseri,Nazanin Naseri ,Fatemeh Bahador

15:15-15:30 P1-04

Available Status Screening Of Breast Cancer In Health

Services Providers Of Tabriz University Of Medical

Sciences In 2018

Masoumeh Ansari - Fatemeh Mohammadi - Aziza Behroozi

15:30-15:45 P1-05

Frequency Distribution Of Socio-Personal

Characteristics In Women Under Treatment For Breast

Cancer

Fahimeh Sehati Shafaee, Dr. Mojgan Mirghafourvand ,

Jalileh Amirzehni 15:45-16:00 P1-06

Comparing The Personality Subtypes And Attachment

Styles Of Women With Advanced Breast Cancer And

Breast Cancer Survivors: A Qualitative Study

Neda Shahvaroughi Farahani, Hossein Eskandari,

Ahmad Borjali 16:00-16:15 P1-07

40 40


Poster Presentation


first day ( Unit 2)


The Relationship Between Breastfeeding And Breast

Cancer

Mehdi Asadi ,Soodabeh Shahidsales, Masoumeh Nouri,

Mina Khani, Aghigh Ziaeemehr, Arash Arianpoor

14:30-14:45 P2-01

Effect Of Nurses' Support And Educational Care On

The Quality Of Life Of Women With Breast

Cancer Referring To Omid Hospital In Mashhad In

2018

Mehdi Asadi, Soodabeh Shahidsales, Masoumeh Nouri, Mina Khani Aghigh Ziaeemehr,

Arash Arianpoor

14:45-15:00 P2-02

Prevalence Of Sexual Dysfunction And

Relationship With Tamoxifen Among Women Of Reproductive Age With Breast Cancer In Bushehr

City

Rezvan Sohrabi Nejad , Hakimeh Vahed Parast, Razieh

Bagherzadeh, Tayebeh Gharibi, Farkhondeh

Mahboudi

15:00-15:15 P2-03

The Relationship Between Spiritual Health And Sleep

Quality In Adults With Diabetes

Mehri Bozorg Nejad

Fatemeh Mohaddes Ardebili 15:15-15:30 P2-04

Comparison Of The Use Of Varicose Socks With And

Without Lower Limb Massage In Susceptible

Women With Breast Cancer Undergoing

Chemotherapy: Clinical Trial

Dara Alvandfar1,Mohammad Reza Katani,2 Nafiseh Arefi3,

Abbasali Dorosti4, Majid Montazer5

15:30-15:45 P2-05

Passive Smoking And Risk Of Breast Cancer Among

Woman In Tonekabon City Maryam Avar 15:45-16:00 P2-06



41


Poster Presentation


first day ( Unit 3 )

2019 February 20 , Wednesday


The Relation Of Socio-Personal Characteristics

With Subdomains Of Financial Problems Of

Women Under Treatment For Breast Cancer

Fahimeh Sehati Shafaee, Dr. Mojgan Mirghafourvand,

Jalileh Amirzehni 14:30-14:45 P3-01

Supportive Care Needs Of Iranian Breast Cancer

Patients

Fatemeh Mirzaei , Azizeh Farshbaf-Khalili Roghaiyeh Nourizadeh

14:45-15:00 P3-02

Mammography Perceptions Among Women In An Iranian Setting: A Qualitative Study

Mardi Afrouz, Refahi soheila Madadzadeh Mitra

15:00-15:15 P3-03

The Effect Of Spirituality Training In Group On Quality

Of Life And Body Image Caused By Chemotherapy In

Breast Cancer Patients

Nasrin Elahi, Safa Najafi: 15:15-15:30 P3-04

The Prevalence Of Rumination Disorder And

Some Related Factors Among Women With Breast Cancer

At The Age Of Fertility In Bushehr City

Rezvan Sohrabi Nejad, Hakimeh Vahed Parast,

Razieh Bagherzadeh, Tayebeh Gharibi,

Farkhondeh Mahboudi

15:30-15:45 P3-05

Evaluating Changes In Sexual Functioning Of Breast Cancer Women During The Phase Of

Radiotherapy

Golazin Bahiraei, Camelia Rohani

15:45-16:00 P3-06

Knowledge, Health Beliefs And Practice Of Isfahan City

Health Volunteers About Self Breast Examination: A Cross-

Sectional Study Based On Health Belief Model

Sanaz Nasiri Isfahani, Mohtasham Ghafari,

Naser Rajabi, Hamid Souri, Hussein Hatami

16:00-16:15 P3-07

42 42


Poster Presentation


Second day (Unit 4)

2019 February 21 , Thursday


Knowledge Practice Of Breast Self-Examination

Among Female Students In Torbat Heydarye

Universitys

Majid Hassanzadeh Sedighe Abbaspour, Zohre

Zandy.Hamideh yaghoby 14:30-14:45 P4-01

Knowledge Of Chemotherapy Induced Amenorrhea In Breast

Cancer

Majid Hassanzadeh SedigheA bbaspour, Zohre


Risk Factors For Breast Cancer In Women 25 To 49

Years Case Control Study

Marzbani Behjat Taymoori Parvaneh Marzbani Behnaz

Nouri Bijan4 Shahabadi Sara 15:00-15:15 P4-03

Evidence Of Decreasing OAR (Lungs, Ribs, Skin)

Absorption Dose By Increasing The Number Of

Lumen In Breast Brachytherapy Applicators

With MCNP

Fatemeh Mahdavi 15:15-15:30 P4-04

Comparing Breast Cancer In The World And Iran, 2008-

2018 Yousef Bashiri 15:30-15:45 P4-05

Improving Soluble Expression Of A Single-

Chain Antibody Pertuzumab By Co-Expression Of

Chaperones

Amir Mirzapour Estabragh, Vajihe Akbari, Hamid Mir

Mohammad Sadeghi 15:45-16:00 P4-06

Investigating The Relationship Between The 206 A / T Polymorphism Of

VEGF Gene And Breast Cancer In Women Of West

Azarbaijan Province

Sasan Talaneh, Zahra Azad,Razieh Azad-Ramin

Nouri, Morteza Hakimian 16:00-16:15 P4-07

43


Poster Presentation


Second day (Unit 5)



Central Memory CD8+ T Cells In Tumor Draining Lymph

Nodes Of Breast Cancer Patients

Yasmin Vahidi, Abdol-Rasoul Talei,

Abbas Ghaderi, Zahra Faghih 14:30-14:45 P5-01

The Germline Pathogenic Variants In A Patient With

Familial Squamous Cell Carcinoma Of Breast

Mina Amin, Elaheh Mahmoodi khaledi, Sina Narrei, Mehrdad Zeinalian

14:45-15:00 P5-02

The Relationship Between Psychological Symptoms

And Quality Of Life In Women With Breast Cancer

Bahare Sadat Nayeb-ol Sadri, Tabassom saeid par var

15:00-15:15 P5-03

Predictors Of Breast Self - Examination Among

Midwifery Students Using Health Belief Model

Taiebeh nekoee, Maryam monkashef

15:15-15:30 P5-04

Occupational Performance Problems In Women With

Breast Cancer



Spatial Structure Of Breast Cancer Using Poisson

Generalized Linear Mixed Model In Iran (2004-9)

Mansour Rezaei, Abdullah Jalilian, Soodeh Shahsavari,

Behzad Mahaki , Maryam Veismoradi

15:45-16:00 P5-06

Quality Of Life In Patients With Breast Cancer And Its

Related Factors In Yazd City In 2015

Fereshteh Eidy, hosein fallahzade, mohammad forat yazdi, Maryam Rabie, fariba

Zare ,erfan javanmardi

16:00-16:15 P5-07

44 44


Poster Presentation


Second day (Unit 6)



Monomethyl Auristatin E As A Potent Cytotoxic Small

Molecule For Development Of Antibody-Drug

Conjugates Against Breast Cancer

Meghdad Abdollahpour-Alitappeh, Zahra Keshtkaran, Mohammad Hossein karimi, Majid Lotfinia4 Esmaeil Kavi

14:30-14:45 P6-01

Cytotoxic Effects Of Nanoparticles Copolymer

Drug Carrier’s Quercetin On Breast Cancer Stem Cells

Rana Mohammad Taghi Kashi,

Hakimeh Zali,Saeed Hesami Tackallou

14:45-15:00 P6-02

Exploring Of Perceptions Of Iranian Women With Breast Cancer Regarding The Role

Of Spiritual Self-Care Activities In The Promotion

Of Hope

Maryam Sheikhpourkhani, Abbas Abbaszadeh, Fariba

Borhani and Maryam Rassouli 15:00-15:15 P6-03

The Relation Of Lymphedema And Activities

Of Daily Living In Women With Breast Cancer-Related

Lymphedema

Majid Hassanzadeh. Dr Dehghan.

SedigheA bbaspour, Zohre Zandy.Hamideh yaghoby

15:15-15:30 P6-04

Quality Of Life And Its Relation With Perceived

Stress And Self-Esteem In Women Under Breast

Cancer Treatment



Illness Perceptions In Women With Breast Cancer

Fatemeh Mirzaei, Azizeh Farshbaf-Khalili , Roghaiyeh Nourizadeh

15:45-16:00 P6-06

Effectiveness Of Short-Term Psychotherapy Based On

Stress Management Training On The Control Of

Anger And Emotions In Patients With Breast Cancer

Ehsan Ebrahimi, Ali Taghinezhad, Mehri Alikhani

16:00-16:15 P6-07

45


Poster Presentation


Third day (Unit 1)

2019 February 22 , FridaySUBJECT AUTHOR TIME CODE

The Relationship Of Health Belief And Breast Self-

Examination Among University Students In Torbat Heydareye

Majid Hassanzadeh . Dr Dehghan.

SedigheA bbaspour, Zohre Zandy.Hamideh

yaghoby

9:00-9:20 P1-01

Evaluation Of Anti- Cancer Properties Of Chamomile Extract In Breast Cancer Cell Line MCF-7

Batool Bonjari , Hamid Reza Rahimi , Reza

Assaran Darban 9:20-9:40 P1-02

The Combination Of Coffee And Tamoxifen Is Effective Against

Breast Cancer

Ghadiriyan Shahrazad, Jafarzadeh mehrzad,

Mohammad Najafi 9:40-10:00 P1-03

A Qualitative Study In Iranian Women With Breast Cancer

Sharareh Zeighami mohammadi,

Sima Mohammad Khan Kermanshahi, Zohreh Vanak

10:00-10:20 P1-04

The Effectiveness Of Religious-Spiritual Education On The Self-Efficacy Of Women With Breast

Cancer

Farzane Nasiri, Zohre Keshavarz, Mohamadhasan

Davazdahemami, Saeed Karimkhani Zandi ,

Malihe Nasiri

10:20-10:40 P1-05

Application Of PEN-3 Model In Training Breast Cancer

Screening Behaviors Among Female Teachers Of Isfahan

Elaheh Shoushtari Moghaddam,

Hossein Shahnazi, Akbar Hassanzadeh

10:40-11:00 P1-06

Caffeic Acid And Over Expression Of P21 In Breast Cancer Cells

(MCF-7)

Hamid Cheshomi, Mohammad

Hosseinzadeh Hesari, Gholam Hossein

Ghasemzadeh

11:00-11:20 P1-07

https://www.ncbi.nlm.nih.gov/pubmed/?term=Mohammad%20Khan%20Kermanshahi%20S%5BAuthor%5D&cauthor=true&cauthor_uid=26290751

https://www.ncbi.nlm.nih.gov/pubmed/?term=Mohammad%20Khan%20Kermanshahi%20S%5BAuthor%5D&cauthor=true&cauthor_uid=26290751

46 46


Poster Presentation


Third day (Unit 2)

2019 February 22 , Friday


Comparison Of Serum Levels Of Microrna-155 In Breast

Cancer Patients In Terms Of Progesterone Receptor And

Estrogen Receptor

Fatemeh Hosseini, Mojahed Vahid

pouresmaeil, Amir Amirabadi;

Amir Hossein Aalami, Mahdi Ghasemi Rad

9:00-9:20 P2-01

The Study Associations Of Haplotypes Of Xrcc3 Gene

With Risk Of Breast Cancer In Iranian Women Population

Milad Pezeshki, Jamshid Ansari

9:20-9:40 P2-02

Association Of Cdh1 And Tert Single Nucleotide

Polymorphisms With Susceptibility To Familial

Breast Cancer Risk

Mahsa Bagherpour, Kamelia Gharibzad ,

Hossein Rassi 9:40-10:00 P2-03

Overexpression Of Serum Microrna-140-3p In

Premenopausal Women With Newly Diagnosed Breast

Cancer

Nadia Heydari,

Novin Nikbakhsh, Farzin Sadeghi,

Nazila Farnoush, Soraya Khafri, Milad Bastami, Hadi Parsian

10:00-10:20 P2-04

In Silico Design Of A Novel Peptide Inhibitor Derivative

Of Pediocin Cp2 Affecting Breast Cancer

EnsiehsadatEmadi, SomayehReiisi

10:20-10:40 P2-05

Quantification Of Angiogenic Factors In Breast Cancer And

Assessment Of Their Clinic Pathological Correlations

Mahboobeh Razmkhah , Negin Rahmani , Parisa Karimzadeh, Somayeh Rezaeifard, Fatemeh

Eghbali, Zahra Faghih

10:40-11:00 P2-06

47


Poster Presentation


Third day (Unit 3)


Fer 1 Like Protein 4 (FER1L4) Long None Coding RNA And

RB1 Cerna Network Expression Analysis In Breast Cancer

Tissues And Adjacent Non-Cancerous Tissues Of Iranian

Turkish Breast Cancer Patients

Zeinab Shaghaghi Torkdari, Mohammad Khalaj Kondori, Mohammad Ali Hosseinpour

Feizi, Vahid Montazeri 9:00-9:20 P3-01

Investigating The Relationship Between The 206 A / T

Polymorphism Of VEGF Gene And Breast Cancer In Women Of West Azarbaijan Province

Sasan Talaneh, Zahra Azad, Razieh Azad, Ramin Nouri,

Morteza Hakimian 9:20-9:40 P3-02

Cloning And Expression Of Pcmv3-Noggin-GFP Spark In

Breast Cancer Cell Line, MCF-7

Aghvami Tehrani A, Latifi navid S, Zahri Sagha M 9:40-10:00 P3-03

Suppressor Of Cytokine Signaling (SOCS)Genes Are Downregulated In Breast

Cancer

Mohammad Taheri, Soudeh Ghafouri-Fard,

Naghmeh Abbasi, Hossein Mohammad-Rahimi

10:00-10:20 P3-04

Comparison Of Cytotoxicity Of Three Natural Phenolic

Compounds On MCF-7 Cell Line

Hamid Cheshomi, Mohammad Hosseinzadeh

Hesari 10:20-10:40 P3-05

Studying The Expression Of TCEB1 In Tumoral And

Marginal Tissues Of The People With Breast Cancer

Mahsa Tarighi, Mohammad Khalaj-kondoriMina

Zafarpiran10:40-11:00 P3-06

Effect Of Bfgf Peptide Antagonist On Mouse Model

Breast Tumor Through ERK/MAPK And PI3K/AKT

Signaling Pathways

Mehrzad Jafarzadeh , Shahrazad Ghadiriyan ,

Mohsen Asghari, Mohammad Taghi Joghataei ,

Mohammad Hashemi Bahremani, Kazem

Mousavizadeh

11:00-11:20 P3-07

48 48


Poster Presentation


49



Oral Presentation

4th International GI Cancer Congress 21-22 Feb / Tehran / Iran

50

4th International GI Cancer Congress


Scientific Program

51



Oral Presentation

Scientific Program


52



Scientific Program

First day Thursday, 21 Feb 2019

4th International Gastro Intestinal Cancer Congress (main hall)

Speaker Title Time Speaking code

Holly Quran & National Anthem of the Islamic Republic of Iran

7:50 – 8:00

Panel: Practical Solutions to Reduce the Financial Burden of Cancer

Panel Coordinator: Prof. M.E Akbari Panel members: Dr. I Harirchi (Surgeon), Dr. GH Jan

babaei (hematologist Oncologist), Dr. M R Vaez Mahdavi (Health sciences), Dr. A Ghanbari

Motlagh (radiotherapist oncologist), Dr. M R Zafar Ghandi (Surgeon), Dr. SH Haghighat (Epidemiologist), Dr. M Akbari (Health sciences),

Dr. P Hosseinpour (pathologist), Dr. A Norouzi (Health sciences), Mr. T Mouhebati (Health sciences),

Dr. H Souri (Epidemiologist), Dr. A Moradi(pathologist)

8:00 – 9:30

Prof. M.E Akbari (head of cancer

research center and congresses)

Welcoming Message 9:30 – 9:45

Dr. S Namaki (Minister of Health

and Medical Education)

Opening Notes 9:45 – 10:00

Appreciation of Honorable Prof. S A Malek Hoseini 10:00 – 10:30 Break 10:30 – 11:00

Chairmen: Dr. J Khoshnevis, Prof. SA Malek Hoseini, Dr. R Kianmanesh

Dr. R Kianmanesh (surgeon)

Neuroendocrine Pancreas Tumor 11:00 – 11:15 01-01

Dr. S Nikeghbalian (fellowship of liver

transplantation)

Modern Techniques in Surgery of Pancreas Tumors

11:15 – 11:30 01-02

Dr. B Ghavami (surgeon)

Pancreatic Surgery with Laparoscopy

11:30 – 11:45 01-03

Dr. S Hafezi Bakhtiari

(pathologist, UofT)

Whipple Specimen: a Pathologist Perspective

11:45 – 12:00 01-04

Dr. A Sadeghi (gastroenterologist)

The Role of Imaging in Pancreatic Cancer: Diagnosis and Staging

12:00 – 12:15 01-05

53 21-22 Feb 2019, Tehran. Iran


Poster Presentation

Panel: Diagnosis and Treatment of Pancreatic Cancer Panel Coordinator: Dr. S Nikeghbalian

Panel members: Dr. R Kianmanesh (surgeon), Dr. N Mansour Moshtaghi (fellowship of cancer

surgery), Dr. B Kazeminejad (pathologist), Dr. Z Kamali (pathologist), Dr. M Boroumand (radiotherapist

oncologist), Dr. M Saneitaheri (radiologist), Dr. A Sadeghi (gastroenterologist), Dr. H Rezvani

(hematologist Oncologist), Dr. M Dehghani (liver surgeon)

12:15 - 13:30

Pray and Lunch 13:30 – 14:30 Chairmen: Dr. S R Mousavi (vascular surgeon), Dr. I Harirchi (cancer surgeon), Dr. R Malekzadeh (gastroenterologist), Dr. S Nikeghbalian (fellowship of liver

transplantation) Dr. R Kianmanesh

(surgeon) Liver Colon Metastasis/

Neuroendocrine Liver Tumor 14:30 – 14:45 01-06

Dr. B Salehi (gastroenterologist)

Diagnostic Technique for Residue of Liver Tumor

14:45 – 15:00 01-07

Dr. M Saberafsharian (pathologist)

Pathologic Categorization of Liver Tumors

15:00 – 15:15 01-08

Dr. M Abdolahad (Electrotechnical

Sergeon)

Metas-Chip, an Integrated System for Detecting the Metastasis in

Secondary Sites 15:15-15:30 01-09

Break 15:30 – 16:00 Panel: Diagnosis and Treatment of Liver Cancer

Panel Coordinator: Dr. R Kianmanesh Panel members: Dr. J Shakeri (fellowship of cancer

surgery), Dr. H Nemati (cancer surgeon), Dr. F Bidari (pathologist), Dr. SH Sabeti (pathologist), Dr. H R

Haghighatkhah (radiologist), Dr. N Zendehdel (gastroenterologist), Dr. M Sanei (radiotherapist

oncologist), Dr. B Sanei (fellowship of liver surgeon)

16:00 – 17:30

54



Scientific Program

Second day Friday, 22 Feb 2019

4th International Gastro Intestinal Cancer Congress (main hall)

Speaker Title Time Speaking code Chairmen:

Dr. I Fazel, Dr. H Peirovi, Dr. H R Haghighat khah, Dr. A Bidari, Dr. H Attarian Dr. F Moradian

(fellowship of cancer surgery)

Epidemiology of Gastric Cancer

8:00 – 8:15 02-01

Prof. S A Malek Hoseini (transplantationist)

Important Aspects of Gastric Cancer Surgery

8:15 – 8:40 02-02

Dr. P Dehghan (radiologist) Radiologic Presentation in

Gastric Cancer 8:40 – 8:55 02-03

Dr. S Abdi (gastroenterologist)

Gastric Polyps 8:55 – 9:10 02-04

Dr. K Tulabi (surgeon) Laparoscopic Upper GI

Cancer 9:10- 9:30 02-05

Panel: Diagnosis and Treatment of Gastric Cancer Panel's Coordinator: Prof. S A Malek hoseini

Panel's members: Dr. F Moradian (fellowship of cancer surgery), Dr. H Hajizadeh fallah (pathologist),

Dr. A Mafi (radiotherapist oncologist), Dr. P Dehghan (radiologist), Dr. M Forutan (gastroenterologist),

Dr. M Houshiary (radiotherapist oncologist), Dr. S Hafezi Bakhtiari (GI pathologist, UofT),

M Dehghani (liver surgeon)

9:30 – 11:00

Break 11:00 – 11:30 Chairmen: Dr. M S fazeli (colorectal surgeon), Dr. A Afshar fard (surgeon),

Dr. M R Kalantarmotamedi (surgeon) Dr. M Saneitaheri

(radiologist) Radiology Status in

Diagnosis of Colon Tumors 11:30 – 11:50 02-06

Dr. SH Shahrokh (gastroenterologist)

Diagnosis Approach for Colon Cancer

11:50 – 12:10 02-07

Dr. M Mozafar (surgeon)

Treatment of Patients with Colon Cancer and

Aneurysm Aorta: do's and don'ts

12:10 – 12:30 02-08

Dr. S Hafezi Bakhtiari (GI pathologist, UofT)

Predictive and Prognostic Role of Some Pathology Findings in Colorectal

Cancer

12:30 – 12:45 02-09



Poster Presentation

Dr. J Khoshnevis (surgeon)

Report of Surgery Results for Esophageal Cancer with

Oringer’s Technique in Shohada Tajrish Hospital

(25 Years)

12:45 – 13:00 02-10

Prayer and Lunch 13:00 – 14:00 Panel: Colon Cancer

Panel Coordinator: Dr. H R Zamani Panel members: Dr. B Ghavami (surgeon), Dr. M

Samsami (fellowship of cancer surgery), Dr. S Hafezi Bakhtiari

(GI pathologist, UofT), Dr. A yaghubi juibari (radiotherapist oncologist), Dr. S A Astani (radiolosist),

Dr. SH Shahrokh (gastroenterologist), Dr. F S Anaraki (colorectal surgeon)

14:00 – 15:30

Break 15:30 – 16:00 Panel: nutrition in cancer

Panel coordinator: Prof. M.E Akbari Panel members: Dr. S H Davoodi (nutritionist),

Dr. S Doaei (nutritionist), Dr. M Gholamalizaeh (Phd by research candidate), Dr. T Rezanistani (nutritionist),

Dr. N Khoshnevis (nutritionist), Dr. F Moradian (fellowship of cancer surgery), Dr. M Shadnoush

(nutritionist)

16:00 – 17:30

56



Scientific Program



Poster Presentation

Poster Presentation




Poster Presentation


2019 February 21 ,Thursday

SUBJECT AUTHOR TIME CODE Existence Of Direct Correlation Between The Methylation Rate

Of Individual Cpgs Present In CYP1A1 Gene Cis-Acting

Element

Sadeghi-Amiri L, Barzegar A, Nikbakhsh-Zati N,

Mehraban P

11:00-11:15 P1-01

Relationship Between Global Incidence And Mortality Rates Of Stomach Cancer With The

Human Development Index: An Ecological Study

Mokhtar Soheylizad, Salman Khazaei

11:15-11:30 P1-02

The Effects Of Sodium Butyrate On The Expression Of LHX1

Gene As A Diagnostic Biomarker In HCT-116

Colorectal Cancer Cell Line

Mahsa ghiaghi, Flora Forouzesh

11:30-11:45 P1-03

Comparison Study Of The Methylation Moieties Of The

CYP1A1 Gene Promoter In Gastric Cancer Patients

Sadeghi-Amiri L, Barzegar A, Nikbakhsh-Zati N,

Mehraban P

11:45-12:00 P1-04

Showing The Difference Between Results Of Prognostic

Factors On Survival Of Colorectal Cancer Patients By Using A New Survival Analysis

Method

Haleh Aghamolaey, Ramin Aghamolaei, Ahmad

Reza Baghestani, Mohammad Esmaeil Akbari

12:00-12:15 P1-05

E Incidence And Risk Factors Of Venous Thromboembolism

In Iranian Inpatients With Inflammatory Bowel Disease: A Retrospective Cohort Study

Seyed Ehsan Asadi, Ali Bagheri-Elahe

Mohtasham, Ahmad Rahimi

12:15-12:30 P1-06

Circulating ghrelin levels and susceptibility to colorectal

cancer

Hamid Farahani, Kalhor Narges, Sara Afshari,

Fatemeh Mohammadi, Zahra Farahani

12:30-12:45 P1-07



Poster Presentation



SUBJECT AUTHOR TIME CODE The Effect Of Opium On

Esophagus Cancer: A Systematic Review And Meta-Analysis

Azad Fatahi , Leili Tapak, Zahra

Cheraghi 11:00-11:15 P2-01

Role Of Mirnas As New Biomarkers In Diagnosis Of Hepatocellular Carcinoma

Amir Hossein Aalami

11:15-11:30 P2-02

Evaluation Of Cytotoxic Effect Of Betatrophin On Hepg2 Cell-Line

By MTT ASSAY

Nastaran Monzavi, Seyed Jalal Zargar, Nematollah

Gheibi 11:30-11:45 P2-03

Comparative Study Of Effect Of Cucurbitacin E, D And I On

Apoptotic Gene Expression In SW-480 Colon Cancer Cell Line

Mohammad Reza Sheikhi, Seyed Jalal Zargar

11:45-12:00 P2-04

Colon Complications In Pelvic Radiotherapy For Gynecological

Cancer, Case Series Study And Literature Review

Neda Nozari 12:00-12:15 P2-05

Silibinin Upregulates E-Cadherin Expression In MKN-45 Human

Gastric Cancer Cells

Ebrahim Faghihloo

12:15-12:30 P2-06

Evaluation of knowledge, sensitivity of Catching and

Perceived Severity of colorectal cancers in nursing students of

Neyshabour University of Medical Sciences in 2018

Seyyedeh Sara Afrazandeh,Nadia Naseri,

Nazanin Naseri

12:30-12:45 P2-07



Poster Presentation


2019 February 21 , Thursday SUBJECT AUTHOR TIME CODE

Investigating the expression of FGF19 gene as an effective gene

for the invasive behavior of cancer cells in patients with

colorectal cancer

Reza Yavari, Armin Gharibi 11:00-11:15 P3-01

Evaluation of Symptoms In Patients With Cancer Receiving

Chemotherapy From The Perspective Of Palliative Care In

Kashan, Iran, 2017

Fereshteh jalili, Negin Masoudi Alavi 11:15-11:30 P3-02

Evaluation of expression of miR-223 in serum of patients with a

gastric cancer undergoing surgery or chemotherapy

Amir Hossein Aalami, Vahid Pouresmaeil ,

Amir Amirabadi, Fatemeh Hosseini

Mojahed, Mahdi Ghasemi Rad

11:30-11:45 P3-03

Regulation of β-Catenin signaling by Gq class of G-proteins in colon

cancer cells

Nasim Forghani and S Mahmoud A Najafi 11:45-12:00 P3-04

Association of agricultural pesticides and gastric cancer

risk

Leili Sadeghi Amiri, Tiziano Verri, Ali Barzegar

12:00-12:15 P3-05

Investigation of the effects of Cucurbitacin D from Ecballium elaterium (L.) A. Rich on LC-3

gene expression in human gastric cancer cell line AGS

Naser Jafargholizadeh, Seyed Jalal Zargar

12:15-12:30 P3-06

Prevalence of H. pylori in patients with colorectal cancer; A systematic review and meta-

analysis

Afsoon Taghavi, Bahareh Hajikhani, Masoud

Dadashi, Zahra Jalili, Shahihn Bolouri, Fatemeh Fallah

12:30-12:45 P3-07

http://nmsjournal.com/?page=search&article_author_fname=Negin&article_author_mname=&article_author_lname=Masoudi%20Alavi&do_search=1&type=authors



Poster Presentation



SUBJECT AUTHOR TIME CODE The Role Of Gαq Signaling On

Β-Catenin Expression In HEK293T Cells

Nahid Khosronezhad , S Mahmoud A Najafi

14:30-14:45 P1-01

Mast Cell-Produced Prostaglandin D2 Prevents Colitis And Colitis-Related

Colon Cancer In Mice

Ali Nouri, Parisa Valipour, Fatemeh Heibati, Esfandiar

Heidarian

14:45-15:00 P1-02

Laparoscopic Jejunostomy: A Simple Valuable Procedure

Farzad Vaghef Davari ,Mohammad

Shirkhoda ,Rezvan Hashemi,Amirmohsen

Jalaeefar

15:00-15:15 P1-03

Targeted Cytotoxicity Of Bilayer Nanogel Containing Oxaliplatin On Colon Cancer

Cell Line (HT29) And Analysis Of BAX And Bcl2 Gene

Expression

Pooneh Movahedi Shad

15:15-15:30 P1-04

Antitumor Effect Of Aspirin On WNT Signalling Pathways In Colorectal Cancer Cell Line

Malihe Bagheri, AmirReza Hesari, Parisa ZiaSarabi,

Zahra Aghasi, Faezeh Ghasemi

15:30-15:45 P1-05

Study Of Methylation Status In APC Gene In Colorectal Cancer

Patient

Soheila Asoudeh, Fatemeh Asoudeh

15:45-16:00 P1-06



Poster Presentation



SUBJECT AUTHOR TIME CODE Epidemiological Study Of

Death Rate From Gastrointestinal Cancers In

Qazvin Province (2015)

Mina Shahsavari, Solmaz Farokhzad,

Dr Ardeshir Alizadeh Shahrivar, Tahereh Rezagoli

14:30-14:45 P2-01

The Study Of Rosa Canina L Extract On Bcl_2 And Bax

Genes Expression In Cancerous Cell Line AGS

Masoume Dastvar, Zahra deilami khiabani

14:45-15:00 P2-02

Experiences Of Children When Understand Cancer

Of Their Mothers: A Phenomenology Analysis

Manijeh Firoozi, 15:00-15:15 P2-03

The Effect Of Verbascoside On HIF-1α Expression As Valuable Metastasis And

Angiogenesis Factor In HT-29 Colon Cancer Cells

Danial Seyfia, Seyed Bahram Behzada, Mohammad Nabiunib,

Kazem Parivarc, Mohammad tahmasebc, Elaheh Aminic

15:15-15:30 P2-04

Evaluation Of Immunohistochemical

Expression Of Survivin And Its Correlation With -31G/C

Gene Polymorphism In Colorectal Cancer

Zahra Heidari ,Hamidreza MahmoudzadehSagheb,

AsiyehHakimi, Bita Moudi

15:30-15:45 P2-05

Overexpression Of Mir146a-5p, As A Novel

Prognostic Marker, Inhibits Migration Of Human HT-29 Colorectal Cancer Cells Via

Down-Regulating Metastasis-Related Genes

Expression

Saeed Noorolyai , Ahad Mokhtarzadeh,

Elham Baghbani, Amir Baghbanzadeh kojabad,

Behzad Baradaran

15:45-16:00 P2-06

http://www.icb2017.com/en/mtm.php?o=169&p=2092&a=1&n=masoome-dastvar

http://www.icb2017.com/en/mtm.php?o=169&p=2092&a=2&n=zahra-deilami-khiabani



Poster Presentation


2019 February 21 ,Thursday SUBJECT AUTHOR TIME CODE

Dietary Patterns And The Risk Of Colorectal Cancer

And Adenoma

Alireza Bahrami, Ehsan Hejazi,

Azita Hekmatdoost, Amir Sadeghi

14:30-14:45 P3-01

Bioinformatics Assessment Of The Targetome Signaling Pathways Hsa-Mir-544a And

Associated SNP Function (Rs12245) In People With

Colorectal Cancer

Afrooz Shekarchizadeh, Mansoureh Azadeh,

Atefeh Zamani

14:45-15:00 P3-02

Primary Sarcoma Of The Pancreas, A Case Report With

Review Of Literature

Dr.Norouzi Alireza, Dr.Taghipour Hamed, Dr.pouladi Yasamin

15:00-15:15 P3-03

GPC3 Expression At The Mrna Level In The Colorectal

Cancer

Sonia Azizpour, Razieh Ezati, Razieh Amini

15:15-15:30 P3-04

Correlation Of Lncrna PVT1 Upregulation With Advanced

Stages And Invasion In Esophageal Squamous Cell Carcinoma (ESCC) Patients.

Zahra roohinejad , Davood Sabour ,

Mohammad Shafiee , Shabbou Bahramian,

Reza Sahebi

15:30-15:45 P3-05

Factors Associated With Risk Of Colorectal Cancer

Recurrence Following Initial Treatment: A 10-Year Cohort

Study

Parisa Mohammadi, Fateme Sadat Miremad,

Mojtaba Keikha, Mostafa Dianatinasab

16:00-16:15 P3-06



Poster Presentation

Second day ( Unit 4 )

2019 February 22 ,Friday

SUBJECT AUTHOR TIME CODE Determination The Effects Of Genistein On Caspase-3

And P-38 Mapk Gene Expression In Gastric Cancer AGS Cell Lines.

Neda Ghasemkhani, Iraj Khodadadi,

Gholamreza Shafiei 9:00-9:20 P4-01

Hypoxia-Inducible Factor 1-Alpha, (Hif-1A), Tend To Over-Expressed In High

Tumor Stage In Esophageal Squamous Cell Carcinoma

(ESCC)

Shabbou Bahramian, Reza Sahebi,

Zahra roohinejad

Mohammad Shafiee

9:20-9:40 P4-02

Identification Of A Novel Mutation In Mitochondrial CO2 Gene In Patients With

Familial Adenomatous Polyposis (FAP)

Zahra Shaker Ardakani, Mohammad Mehdi

Heidari,Mehri Khatami

9:40-10:00 P4-03

The Effect Of Spiritual Counseling On Depression Of Gastric Cancer Patients

Maryam Nasari

10:00-10:20 P4-04

Determine The Survival Rate Of Esophageal Cancer

In Northern Iran: A Systematic Review And

Meta-Analysis

Ahmad Vahednasiri, Morteza Atayi,

Ehsan Aliasghari 10:20-10:40 P4-05

The Role Of Mir-146a-5p And CXCR4 In

Tumorigenesis Of Colorectal Cancer Cells

Reyhaneh Afshar Khamseh, Masoumeh Fakhr Taha,

Arash Javeri

10:40-11:00 P4-06

Epidemiology Of Gastrointestinal Cancers In

Cities Covered By Arak University Of Medical

Sciences: Cross-Sectional Study In 2009 And 2014

Pari Mirshafiei, Javad Nazari, Bahar Shahmohammadi,

Mohsen Farahani, Saeed Amini

11:00-11:20 P4-07



Poster Presentation



Investigating The Scattering Of Stomach

Cancer In Iran

Ehsan Aliasghari, Morteza Atayi,

Ahmad Vahednasiri 9:00-9:20 P5-01

EGFR Inhibitor Resistance In Colorectal Cancer

Haniyeh Bashi zadeh Fakhar, Hakimeh Zali,

Shabnam Jeibouei, Nazanin Ghasemi

9:20-9:40 P5-02

DNA Methylation Regulated Microrna-200b

In Colorectal Polyp And Cancer Tissues In Iranian

Population

Shabnam Tavangarroosta, Vahid Aliasghari, sanaz savabkar ,

Ehsan Nazemalhosseini Mojarad

9:40-10:00 P5-03

Methylation Of CDH11is An Independent

Prognostic Biomarker For Gastric Cancer Patients

Shirin Eyvazi, Vahideh Tarhriz,

Amir Mahdi Khamaneh, Bita Sepehri

10:00-10:20 P5-04

A Survey On Epha5 Methylation Status In

Gastric Adenocarcinoma Patients



10:20-10:40 P5-05

Effects Of Metformin In Combination Of 5-

Fluorouracil On Cell Viability Assay In Gasteric

Cancer Cell Lines

Sahar Moazenrad , Pardis Cheraghali

10:40-11:00 P5-06

Study The Anticancer Effect Of Herbal Carcumin

Extract On HER-2 Expression In Gastric

Adenocarcinoma Cells

Sahar Zarrabi, Zahra Deilami Khiabani

11:00-11:20 P5-07

https://www.ncbi.nlm.nih.gov/pubmed/29077234

https://www.ncbi.nlm.nih.gov/pubmed/29077234



Poster Presentation


2019 February 22 , Friday


Characterization Of Gastric Microbiota In Gastric Cancer

Patients



9:00-9:20 P6-01

In Vitro Analysis Of The Anticancer Properties Of

Cobra Venom In Colorectal Cancer Cell Line

Mahdi Shekarabi, Kamran Pooshang Bagheri,

Delavar Shahbazzadeh

9:20-9:40 P6-02

Clinicopathological Features And Prognosis Of Elderly Gastric Cancer Patients In West Azarbaijan Province

Hesami, R , Entezar Mahdi, R

Khalkhali, H , Esnaashari,O 9:40-10:00 P6-03

Sodium Butyrate Inhibited The Growth Of Colorectal Cancer SW480 Cell Lines.

Arghavan Sheikh , Flora Forouzesh, Mahdi Shabani,

Shahram Zarrabian

10:00-10:20 P6-04

The Study Of The Curcumine Extract On Htert Gene Expression In Gastric

Adenocarcinoma Cells (AGS)

Hamed Boostaniyan , Zahra Deilami Khiabani

10:20-10:40 P6-05

Administration Of Intravenous Infliximab For

Prevention Of Peritoneal Adhesions

Formation In Rats

Saman Nikeghbalian, Homeira Vafaei, Farid Moradian, Kourosh Kazemi, Nader Tanideh,

Leila Shayan, Zahra Nikeghbalian

10:40-11:00 P6-06

Effects Of Curcumin And Ethanolic Turmeric Extract

On Growth And Proliferation Of Cancerous Cells (4T1)

Hooman Yazdanpour, Gholamali Jelodar,

Saeed Nazifi, Mohammad

Movafaghizadeh

11:00-11:20 P6-07



Poster Presentation


2019 February 22 , Friday SUBJECT AUTHOR TIME CODE

Calculation Of Absorbed Dose Rate In The Esophagus, Stomach

And Pancreas By The Mammosite Applicator In Breast

Cancer Brachytherapy With MCNP

Fatemeh Mahdavi 14:30-14:45 P1-01

Assessment Bioinformatics Of Targetum Signaling Pathways

Hsa-Mir-3605-3p And Its Related SNP Function (Rs12977)

In People With Gastric Cancer

Aliasghar Falahiyan Javani, Kamran Ghaedi,

Mohammad Fazilati, Mansoure Azadeh,

Atefeh Zamani

14:45-15:00 P1-02

Study Gastric Cancer In The World And Iran During 2008 To

2018 Yousef Bashiri

15:00-15:15 P1-03

The Effect Of Curcumine Extract On E-Cadherin Gene Expression

In Adenocarcinoma Gastric Cancer Cells

Ali Habashi, Zahra Deilami Khiabani 15:15-15:30 P1-04

Human Epidermal Growth Factor Receptor-2 Assessment

In Cancerous And Precancerous Lesions Of The Stomach In

Presence Of Helicobacter Pylori

Zahra Heidari, Hamidreza

Mahmoudzadeh-Sagheb, Nadia Sheibak, Mehran

Panahi, Setareh Jami

15:30-15:45 P1-05

Investigation Of Five Year Survival Rate And Epidemiologic

Features In Patients With Gastrointestinal Cancers In West

Azerbijan Province

Ahmad Reza Shamshiri, Rabee Hesami,

Koorosh Etemad,Rashid Ramezani,Ali Ghanbari

Motlagh, Kamran Dehghan, Bahram Nemati,

Rasool Entezar Mahdi

15:45-16:00 P1-06



Poster Presentation

Identification and Evaluation of Plasma microRNAs and lncRNAs

as Novel Diagnostic and Prognostic Biomarkers in

Pancreatic Ductal Adenocarcinoma Based on

Bioinformatics Methods

Mohammad Amin Mahmanzar ,

Binazir khanabadi, Reza Mahmanzar,

Shaghayegh Jamshidizadeh ,

Saeedeh sadat Beheshti Shirazi,

Farzaneh Shalileh , Elmira Sadat Tabatabaei, Simin Rezaei, Seyad Ali

Karimifard, Ehsan Nazemalhosseini-

Mojarad, Amir Sadeghi , Hamid Asadzadeh

Aghdaei

16:00-16:15 P1-07



Poster Presentation

Second day ( Unit 2 ) 2019 February 22 ,Friday


Survival Analysis Of Patients With Metastatic Gastric Cancer

Using Cox Regression Model

Touba narimani moghadam,

Moghaddameh Mirzaee, Abbas Bahrampour,

Yunes Jahani, Mehdi Hayatbakhsh

Abbasi, Yousef bashiri

14:30-14:45 P2-01

A Comparative Analysis Of Gene Expression Profile In Liver And Esophagus Cancer By Expressed

Sequence Tags

Mahboobeh Ramezani , Fatemeh Shamsabadi,

Morteza Oladnabi 14:45-15:00 P2--02

NPAS2 Gene Expression In Gastric Cancer

Negar Haghpanah, Zivar Salehi,

Mohammadjavad Mehdipour, Soheila Talesh

Sasani, Keyvan Aminian

15:00-15:15 P2--03

Prevalence Of Helicobacter Pylori Vaca Genotypes In

Paraffin-Embedded Biopsy Samples Prepared From Patients With Upper Gastrointestinal (GI)

Carcinoma

M.Esmaeillou, A. Bahadori,KH. Maleki Chollou, P.

Abedi, Hamed Hassanpour, L. Hasheminejad, N.

samsami,

15:15-15:30 P2--04

Up-Regulation Of Lncrna PVT1 Correlates With Advanced Stages

And Invasion In ESCC Patients.

Zahra roohinejad, Davood Sabour, Mohammad

Shafiee, Shabbou Bahramian, Fatemeh T.

Shamsabadi, Reza Sahebi

15:30-15:45 P2--05

Study The Effect Of Curcumin Extract On Beta-Catenin

Expression In Adenocarcinoma Gastric Cancer Cells

Sanaz Ansarifar, Zahra Deilami Khiabani,

15:45-16:00 P2--06

Evaluation the panel of Plasma circularRNA as Novel

Biomarkers in cholangiocarcinoma Based on

Bioinformatics Methods

Binazir Khanabadi, Mohammad Amin

Mahmanzar, Reza Mahmanzar,

Helia Mojahed Yazdi, Asma Laleh, Elahe Daskar

Abkenar , Mahsa Mousakhan

Bakhtiari, Parnian Jabbari, Ehsan Nazemalhosseini-Mojarad, Amir Sadeghi,

Hamid Asadzadeh Aghdaei

16:00-16:15 P2--07

https://www.ncbi.nlm.nih.gov/pubmed/?term=Abbasi%20MH%5BAuthor%5D&cauthor=true&cauthor_uid=25628852

https://www.ncbi.nlm.nih.gov/pubmed/?term=Abbasi%20MH%5BAuthor%5D&cauthor=true&cauthor_uid=25628852



Poster Presentation


2019 February 22 , Friday SUBJECT AUTHOR TIME CODE

Sodium Butyrate Increased The Expression Of Mir-21 In

Human Colorectal Cancer HCT-116 Cell Line.

Parastoo mohammadi, Flora Forouzesh, Fatemeh

Kouhkan kahangi 14:30-14:45 P3-01

Expected Nausea Related To Chemotherapy Induced

Nausea In Cancer Patients

Zahra Khalili, Mahnaz Khatiban, Mahnaz Moghadari koosha

14:45-15:00 P3-02

The Quality Of Life Of People With Gastrointestinal

Ostomy In Iran

Shadie Kanani

15:00-15:15 P3-03

P16ink4a Immunohistochemical

Expression In Colorectal Adenocarcinoma Compared

To Adenomatous And Normal Tissue Samples

Zahra Heidari , Hamidreza

Mahmoudzadeh Sagheb , Enam Alhagh Charkhat

Gorgich

15:15-15:30 P3-04

Immunohistochemical Expression Of Survivin In

Gastric Cancer And Precancerous Lesions Of The

Stomach

Setareh Jami, Zahra Heidari, Hamidreza Mahmoudzadeh-Sagheb,

Mehran Panahi, Bita Moudi

15:30-15:45 P3-05

Overexpression Of Let-7e Enhances The

Radiosensitivity Of Colorectal Cancer Cells By Directly

Targeting IGF-1R

Pouria samadi, Saeid Afshar,

Rezvan Najafi, Abdolazim Sedighi

Pashaki, Razieh Amini, Ali Mahdavinezhad, Massoud Saidijam

15:45-16:00 P3-06

http://www.strc.ac.ir/en/about-en/faculty/170-english/2014-05-16-05-54-19/about-us/researchgroups/molecularresearchgroup/faculty/275-faculty-members.html

71

NOTE: ............................................................................................................................................... ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. .............................................................................................................................................................

72

............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. ............................................................................................................................................................. .............................................................................................................................................................

dr. mohammad haji aghajani

Documents